Publication | Closed Access

Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)

Breast OncologyOncologyBreast CancerJbcrg-c03 StudyCancer TreatmentMedicineRadiation OncologyNeoadjuvant Chemotherapy